• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Epocrates Ranked #1 Top Medical Reference App Among U.S. Physicians

by Jasmine Pennic 06/10/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Epocrates Ranked #1 Top Medical Reference AppEpocrates, Inc., an athenahealth, Inc. service has been ranked the number one medical reference app on smartphones and tablets among U.S. physicians for the fifth consecutive year, according to Manhattan Research’s 2014 Taking the Pulse® U.S. study.

The newly released Taking the Pulse U.S. study reports on technology adoption and behavior trends among physicians across the U.S. More than 3,000 physicians shared their opinions. Key findings include:

  • Epocrates is #1 – Epocrates is the most popular medical reference application on smartphone and tablet devices among U.S. physician app users.

  • Critical to Workflow – Epocrates users are more likely to use digital resources on their smartphones for professional purposes than the average U.S. physician. 62 percent of physicians who use Epocrates use their smartphones to access clinical content in between patient consults; 39 percent during patient consults.

  • Epocrates Physicians are Frequent Users – Nearly one-third of physicians using Epocrates on a smartphone launch the app three or more times a day.

  • Clinical Content Seekers – While drug references remain one of the top digital resources used by physicians on a smartphone, those who use Epocrates are almost twice as likely as non-Epocrates users to access both drug reference databases and clinical references.

“I have worked in pediatrics for 13 years, and Epocrates has made a big difference in the quality and safety of the care I deliver,” said Dr. Ryan Walley, a pediatrician from Birmingham, Alabama. “I use Epocrates to answer critical questions, and it has never failed me. You can never overestimate the value of accurate peds dosing or information on drug-drug interactions when you need it most.”

To learn more about Epocrates and its latest point-of-care solutions, please visitwww.epocrates.com . 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |